Milestone Scientific Inc. (MLSS)
NYSEAMERICAN: MLSS · Real-Time Price · USD
0.3540
+0.0050 (1.43%)
Dec 5, 2025, 4:00 PM EST - Market closed
Milestone Scientific Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Milestone Scientific stock has a target of 1.00, which predicts a 182.49% increase from the current stock price of 0.35.
Price Target: $1.00 (+182.49%)
Analyst Consensus: Buy
Analyst Ratings
According to 1 stock analyst, the rating for Milestone Scientific is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 2 | 1 |
| Hold | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Buy Maintains $1.25 → $1 | Buy | Maintains | $1.25 → $1 | +182.49% | Nov 20, 2025 |
| Benchmark | Benchmark | Buy Reiterates $1.25 | Buy | Reiterates | $1.25 | +253.11% | Nov 20, 2024 |
| Benchmark | Benchmark | Buy Initiates $1.25 | Buy | Initiates | $1.25 | +253.11% | Oct 10, 2024 |
Financial Forecast
Revenue This Year
9.40M
from 8.63M
Increased by 8.95%
Revenue Next Year
10.11M
from 9.40M
Increased by 7.51%
EPS This Year
-0.07
from -0.06
EPS Next Year
-0.05
from -0.07
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 9.8M | 10.8M | |
| Avg | 9.4M | 10.1M | |
| Low | 9.0M | 9.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 13.2% | 15.0% | |
| Avg | 8.9% | 7.5% | |
| Low | 3.7% | -0.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.06 | -0.03 | |
| Avg | -0.07 | -0.05 | |
| Low | -0.07 | -0.06 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.